Clinical Trial Update: Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting results on prophylaxis for acute graft-versus-host disease after allogeneic peripheral blood hematopoietic cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Acute Graft Versus Host Disease | Phase 2 | Status: COMPLETED | Results posted: 2014-05-05